Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carcinoma of lung
|
995 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.030 | 1.000 | 3 | 2013 | 2017 | ||||||
Malignant neoplasm of lung
|
1000 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.030 | 1.000 | 3 | 2013 | 2017 | ||||||
Primary malignant neoplasm of lung
|
981 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.030 | 1.000 | 3 | 2013 | 2017 | ||||||
Breast Carcinoma
|
2145 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.020 | 1.000 | 2 | 2015 | 2016 | ||||||
Diabetes Mellitus, Non-Insulin-Dependent
|
1598 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.020 | 1.000 | 2 | 2008 | 2010 | ||||||
Malignant neoplasm of breast
|
2154 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.020 | 1.000 | 2 | 2015 | 2016 | ||||||
Age related macular degeneration
|
390 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Asthma
|
714 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Carcinogenesis
|
355 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
cervical cancer
|
257 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Cervix carcinoma
|
266 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Chronic Obstructive Airway Disease
|
301 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Complications of Diabetes Mellitus
|
35 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Congestive heart failure
|
156 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Coronary Artery Disease
|
1022 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Crohn Disease
|
456 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Diabetes Mellitus, Insulin-Dependent
|
388 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Fatty Liver Disease
|
41 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Gestational Diabetes
|
206 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
Heart Diseases
|
44 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Heart failure
|
120 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Left ventricular systolic dysfunction
|
10 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Liver carcinoma
|
769 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Malignant Neoplasms
|
1441 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.010 | 1 | 2015 | 2015 | |||||||
Malignant tumor of cervix
|
245 | 0.658 | 0.480 | 6 | 32184610 | upstream gene variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 |